Home / Inspections / 1022788

FDA Inspection 1022788 — Aurobindo Pharma Limited

Aurobindo Pharma Limited — FEI 3007373532

The FDA completed an inspection of Aurobindo Pharma Limited on June 24, 2017 in Jedcherla Mandal, Mahabubnagar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jedcherla Mandal, Mahabubnagar (India)

Facility

Other inspections at this facility

  • 1169446 (VAI Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1105823 (OAI Fri Sep 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927596 (NAI Fri Mar 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 787128 (NAI Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694644 (VAI Fri Jul 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources